Low Libido in Women: What's Behind the Change
SaveA sudden drop in sex drive usually reflects several factors at once: hormones, medications such as antidepressants, sleep loss, mood, pain with sex, and relationship strain. Desire in women is often more responsive than spontaneous, so context matters. Persistent, distressing low desire lasting 6 months or more may be diagnosable HSDD [1].
Last updated: July 2026
What actually controls desire in women?
Desire in women arises from a mix of biology, psychology, and context rather than a single hormone. Estrogen supports vaginal comfort and lubrication, testosterone contributes to sexual interest, and brain chemistry, stress, and emotional closeness all feed in. Because of this, a change in any one area can ripple into how much interest you feel.
Many women also experience responsive desire rather than spontaneous urges, meaning arousal often comes before the wish for sex rather than after. The American College of Obstetricians and Gynecologists frames female sexual function as multifactorial, which is why no single test explains low libido 1Ref 1American College of Obstetricians and Gynecologists (2019).Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213.ACOG framing of female sexual dysfunction as multifactorial, the distress-plus-6-month criteria for hypoactive sexual desire disorder, medications including SSRIs and hormonal contraception as contributors, and prevalence of distressing low desire around 1 in 10 women. Understanding your own pattern makes the possible causes easier to sort.
Which medical and hormonal causes lower libido?
Physical health drives a large share of desire changes, especially when hormones shift. Thyroid disorders, iron deficiency, diabetes, chronic pain, and depression can all blunt interest, and treating the underlying condition often helps more than anything aimed at desire itself. Falling estrogen during the perimenopausal transition can cause vaginal dryness and discomfort that make sex less appealing.
Hormone therapy produces a small to moderate improvement in sexual function for symptomatic menopausal women, according to a Cochrane review 2Ref 2Nastri CO, Lara LA, Ferriani RA, et al. (2013).Hormone therapy for sexual function in perimenopausal and postmenopausal women.Cochrane review finding hormone therapy produces a small to moderate improvement in sexual function for symptomatic perimenopausal and postmenopausal women. Testosterone's role is narrower: an international society consensus supports it only for postmenopausal women with diagnosed distressing low desire, and no female-specific product is FDA-approved 3Ref 3Davis SR, et al. (International consensus, endorsed by The Endocrine Society and International Menopause Society) (2019).Global Consensus Position Statement on the Use of Testosterone Therapy for Women.International consensus statement that testosterone therapy for women is evidence-based only for postmenopausal hypoactive sexual desire disorder, with no female-specific product approved. In adolescence, by contrast, low desire is rarely hormonal and more often tied to stress or relationships.
Can medications and antidepressants be the reason?
Medications are one of the most overlooked reasons desire falls. Antidepressants, particularly SSRIs, are a well-recognized contributor and can reduce desire, arousal, or the ability to orgasm; the ACOG practice bulletin lists them among common medication causes of sexual dysfunction 1Ref 1American College of Obstetricians and Gynecologists (2019).Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213.ACOG framing of female sexual dysfunction as multifactorial, the distress-plus-6-month criteria for hypoactive sexual desire disorder, medications including SSRIs and hormonal contraception as contributors, and prevalence of distressing low desire around 1 in 10 women. Hormonal contraception affects some women too, though the evidence is mixed and many report no change 1Ref 1American College of Obstetricians and Gynecologists (2019).Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213.ACOG framing of female sexual dysfunction as multifactorial, the distress-plus-6-month criteria for hypoactive sexual desire disorder, medications including SSRIs and hormonal contraception as contributors, and prevalence of distressing low desire around 1 in 10 women.
Other contributors include certain blood pressure drugs, opioids, and heavy alcohol use. Because switching a prescription is a clinical decision, the practical step is a medication review rather than any change on your own. Distressing low desire that meets criteria for a disorder affects roughly 1 in 10 women, and medications are a frequent, and often reversible, piece of that picture 1Ref 1American College of Obstetricians and Gynecologists (2019).Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213.ACOG framing of female sexual dysfunction as multifactorial, the distress-plus-6-month criteria for hypoactive sexual desire disorder, medications including SSRIs and hormonal contraception as contributors, and prevalence of distressing low desire around 1 in 10 women.
How do stress, sleep, and relationships affect sex drive?
Emotional and relational context often matters as much as biology. Chronic stress, poor sleep, resentment, or feeling disconnected from a partner can suppress desire even when hormones and health are normal. Poor sleep alone raises next-day fatigue and lowers interest, and sleep loss can worsen anxiety and low mood, which feed back into desire.
For many couples, a drop in shared desire reflects life load more than any medical problem. Naming what changed, and when, helps separate a relationship pattern from a physical one. Gale can help you organize these threads before a visit so the conversation covers more than hormones.
When low libido is worth a clinician's time
Low libido deserves evaluation when it is persistent, distressing, or paired with other symptoms. A change lasting 6 months or more, pain during sex, unusual fatigue, or a new medication that lines up with the timing are all reasons to raise it with a clinician 1Ref 1American College of Obstetricians and Gynecologists (2019).Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213.ACOG framing of female sexual dysfunction as multifactorial, the distress-plus-6-month criteria for hypoactive sexual desire disorder, medications including SSRIs and hormonal contraception as contributors, and prevalence of distressing low desire around 1 in 10 women. A primary care clinician or gynecologist can check thyroid and iron, review prescriptions, and screen for depression before considering desire-specific options.
A dramatic reason is not required to ask, because sexual health is a legitimate part of a checkup. Preparing a short timeline of what changed helps, and talking to a clinician about sex is more routine than many expect. Gale can help you prepare for that conversation.
Common questions
Related
Sexual health
Stress and Desire: How Burnout Mutes LibidoSexual health
Testosterone for Low Desire: What Evidence SupportsSexual health
Low Desire: When It's Worth a Medical Visit
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
When low libido needs a closer look
- —Pain or bleeding during sex, which is a reason to seek clinician review
- —A sudden loss of desire alongside fatigue, weight change, or hair thinning, which can signal a thyroid or hormonal issue worth evaluating with a clinician
- —Low desire with persistent sadness or loss of interest in most activities, which is a reason to seek a mental health evaluation; if you have thoughts of harming yourself, call or text 988
- —Desire loss that began soon after starting a new medication, which is a reason to ask a clinician for a review
This article is general health education, not medical advice. Whether a change in desire needs treatment depends on your health history and is best sorted out with a primary care clinician or gynecologist.
References
- 1.American College of Obstetricians and Gynecologists (2019). Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000003324 ✓ACOG framing of female sexual dysfunction as multifactorial, the distress-plus-6-month criteria for hypoactive sexual desire disorder, medications including SSRIs and hormonal contraception as contributors, and prevalence of distressing low desire around 1 in 10 women
- 2.Nastri CO, Lara LA, Ferriani RA, et al. (2013). Hormone therapy for sexual function in perimenopausal and postmenopausal women. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD009672.pub2 ✓Cochrane review finding hormone therapy produces a small to moderate improvement in sexual function for symptomatic perimenopausal and postmenopausal women
- 3.Davis SR, et al. (International consensus, endorsed by The Endocrine Society and International Menopause Society) (2019). Global Consensus Position Statement on the Use of Testosterone Therapy for Women. Journal of Clinical Endocrinology & Metabolism. doi:10.1210/jc.2019-01603 ✓International consensus statement that testosterone therapy for women is evidence-based only for postmenopausal hypoactive sexual desire disorder, with no female-specific product approved
3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy